17.87
price up icon1.77%   0.31
after-market アフターアワーズ: 17.85 -0.02 -0.11%
loading
前日終値:
$17.56
開ける:
$17.64
24時間の取引高:
900.30K
Relative Volume:
0.64
時価総額:
$1.76B
収益:
-
当期純損益:
$-44.84M
株価収益率:
-38.02
EPS:
-0.47
ネットキャッシュフロー:
$-44.23M
1週間 パフォーマンス:
-0.17%
1か月 パフォーマンス:
+17.88%
6か月 パフォーマンス:
+46.72%
1年 パフォーマンス:
+57.58%
1日の値動き範囲:
Value
$17.57
$17.99
1週間の範囲:
Value
$17.19
$18.22
52週間の値動き範囲:
Value
$8.9055
$18.90

Ars Pharmaceuticals Inc Stock (SPRY) Company Profile

Name
名前
Ars Pharmaceuticals Inc
Name
セクター
Healthcare (1170)
Name
電話
858-771-9307
Name
住所
11682 EL CAMINO REAL, SUITE 120, SAN DIEGO
Name
職員
160
Name
Twitter
Name
次回の収益日
2024-12-13
Name
最新のSEC提出書
Name
SPRY's Discussions on Twitter

SPRY を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
SPRY
Ars Pharmaceuticals Inc
17.87 1.76B 0 -44.84M -44.23M -0.47
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
469.55 123.00B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
547.93 59.66B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
322.81 41.84B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
577.92 33.98B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
279.16 27.67B 3.81B -644.79M -669.77M -6.24

Ars Pharmaceuticals Inc Stock (SPRY) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-03-07 開始されました Scotiabank Sector Outperform
2025-02-10 開始されました Oppenheimer Outperform
2024-08-20 開始されました Cantor Fitzgerald Overweight
2024-08-13 アップグレード Raymond James Outperform → Strong Buy
2024-08-12 繰り返されました Leerink Partners Outperform
2024-07-25 開始されました Raymond James Outperform
2024-03-05 アップグレード Leerink Partners Market Perform → Outperform
2024-02-20 アップグレード William Blair Mkt Perform → Outperform
2023-09-20 ダウングレード William Blair Outperform → Mkt Perform
2023-01-31 開始されました Wedbush Outperform
2023-01-03 開始されました William Blair Outperform
2022-12-13 開始されました SVB Leerink Outperform
すべてを表示

Ars Pharmaceuticals Inc (SPRY) 最新ニュース

pulisher
Jul 15, 2025

ARS Pharmaceuticals, Inc. (SPRY) is a Great Momentum Stock: Should You Buy? - Yahoo Finance

Jul 15, 2025
pulisher
Jul 15, 2025

Wall Street Analysts See a 78.77% Upside in ARS Pharmaceuticals, Inc. (SPRY): Can the Stock Really Move This High? - Yahoo Finance

Jul 15, 2025
pulisher
Jul 15, 2025

What Makes ARS Pharmaceuticals, Inc. (SPRY) a Good Fit for 'Trend Investing' - Yahoo Finance

Jul 15, 2025
pulisher
Jul 10, 2025

ARS Pharmaceuticals: High Risk High Reward Rollout Of No Needle Epinephrine (SPRY) - Seeking Alpha

Jul 10, 2025
pulisher
Jul 09, 2025

(SPRY) Technical Data - news.stocktradersdaily.com

Jul 09, 2025
pulisher
Jul 09, 2025

ARS Pharmaceuticals: 'Betting On The Come' (NASDAQ:SPRY) - Seeking Alpha

Jul 09, 2025
pulisher
Jul 03, 2025

ARS Pharmaceuticals: Insider Liquidity vs. Institutional Buying – A Contrarian Opportunity? - AInvest

Jul 03, 2025
pulisher
Jul 01, 2025

ARS Pharmaceuticals: Navigating Insider Sales Amid Growth Catalysts - AInvest

Jul 01, 2025
pulisher
Jun 30, 2025

ARS Pharmaceuticals, Inc.(NasdaqGM:SPRY) added to Russell 2000 Growth-Defensive Index - MarketScreener

Jun 30, 2025
pulisher
Jun 27, 2025

ARS Pharmaceuticals (SPRY) Soars 4.48% on Earnings, Partnership - AInvest

Jun 27, 2025
pulisher
Jun 23, 2025

High Growth Tech Stocks in US for June 2025 - simplywall.st

Jun 23, 2025
pulisher
Jun 18, 2025

Learn to Evaluate (SPRY) using the Charts - news.stocktradersdaily.com

Jun 18, 2025
pulisher
Jun 18, 2025

ARS Pharmaceuticals | 6/18/25 - ktnv.com

Jun 18, 2025
pulisher
Jun 18, 2025

FDA Reviewing Oral Epinephrine Film for Possible Approval - Allergic Living

Jun 18, 2025
pulisher
Jun 17, 2025

Asthma Market to Expand Significantly by 2034, States - openPR.com

Jun 17, 2025
pulisher
Jun 17, 2025

Asthma Market to Expand Significantly by 2034, States DelveInsight Report | GSK, AB Science, Areteia Therapeutics, ARS Pharma, AstraZeneca, Pieris Pharma, Sanofi, Cumberland Pharma, Genentech - Barchart.com

Jun 17, 2025
pulisher
Jun 15, 2025

ARS Pharmaceuticals signs agreement with ALK-Abelló A/S for neffy - MSN

Jun 15, 2025
pulisher
Jun 15, 2025

Jim Cramer on ARS Pharmaceuticals: “It’s a Great Flier” - Insider Monkey

Jun 15, 2025
pulisher
Jun 12, 2025

Jim Cramer Discussed These 16 Stocks Recently - Insider Monkey

Jun 12, 2025
pulisher
Jun 09, 2025

ARS Pharmaceuticals Earns Relative Strength Rating Upgrade - Investor's Business Daily

Jun 09, 2025
pulisher
Jun 06, 2025

Long Term Trading Analysis for (SPRY) - news.stocktradersdaily.com

Jun 06, 2025
pulisher
Jun 05, 2025

Bank of America Corp DE Has $1.70 Million Stock Position in ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) - Defense World

Jun 05, 2025
pulisher
Jun 04, 2025

ARS Pharmaceuticals - WBFF

Jun 04, 2025
pulisher
Jun 03, 2025

Ameriprise Financial Inc. Buys 36,928 Shares of ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) - Defense World

Jun 03, 2025
pulisher
Jun 02, 2025

BNP Paribas Financial Markets Purchases New Stake in ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) - Defense World

Jun 02, 2025
pulisher
Jun 02, 2025

ProShare Advisors LLC Buys 3,436 Shares of ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) - Defense World

Jun 02, 2025
pulisher
May 31, 2025

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Has $354,000 Stock Holdings in ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) - Defense World

May 31, 2025
pulisher
May 30, 2025

Deutsche Bank AG Increases Stake in ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) - Defense World

May 30, 2025
pulisher
May 29, 2025

Neffy provides needle-free relief to those with allergic reactions - KOIN.com

May 29, 2025
pulisher
May 28, 2025

ARS brings relief to your whole home - KOIN.com

May 28, 2025
pulisher
May 27, 2025

ARS Pharmaceuticals to Participate in Upcoming Investor Conferences - GlobeNewswire

May 27, 2025
pulisher
May 27, 2025

ARS Pharmaceuticals Leadership Takes Stage at 3 Major Investment Conferences This June - Stock Titan

May 27, 2025
pulisher
May 26, 2025

(SPRY) Trading Advice - news.stocktradersdaily.com

May 26, 2025
pulisher
May 25, 2025

D. E. Shaw & Co. Inc. Decreases Stake in ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) - Defense World

May 25, 2025
pulisher
May 23, 2025

ARS Pharmaceuticals: neffy - WCIV

May 23, 2025
pulisher
May 22, 2025

Exploring US High Growth Tech Stocks In May 2025 - simplywall.st

May 22, 2025
pulisher
May 22, 2025

Brent Saunders Sells 120,000 Shares of ARS Pharmaceuticals Inc (SPRY) - GuruFocus

May 22, 2025
pulisher
May 21, 2025

Expert Dr. Chase shares insights on Neffy for summer allergy season - KOKH

May 21, 2025
pulisher
May 19, 2025

FY2025 EPS Estimates for SPRY Cut by Cantor Fitzgerald - Defense World

May 19, 2025
pulisher
May 19, 2025

ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) Shares Sold by The Manufacturers Life Insurance Company - Defense World

May 19, 2025
pulisher
May 19, 2025

Needle-Free Emergency Epinephrine Now Available for Pediatric Patients - Dermatology Advisor

May 19, 2025
pulisher
May 19, 2025

Leerink Partnrs Has Bearish Outlook for SPRY Q2 Earnings - Defense World

May 19, 2025
pulisher
May 19, 2025

William Blair Brokers Lower Earnings Estimates for SPRY - Defense World

May 19, 2025
pulisher
May 18, 2025

ARS Pharmaceuticals (NASDAQ:SPRY) Trading Up 10.8% – Still a Buy? - Defense World

May 18, 2025
pulisher
May 17, 2025

Price T Rowe Associates Inc. MD Reduces Holdings in ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) - Defense World

May 17, 2025
pulisher
May 17, 2025

ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) Q1 2025 Earnings Call Transcript - MSN

May 17, 2025
pulisher
May 16, 2025

ARS Pharmaceuticals targets 80% commercial coverage for neffy in 2025 while expanding pediatric reach - MSN

May 16, 2025
pulisher
May 15, 2025

Ars Pharmaceuticals’ Neffy Launch Boosts Market Prospects - TipRanks

May 15, 2025
pulisher
May 15, 2025

ARS Pharmaceuticals, Inc. (SPRY) Reports Q1 Loss, Lags Revenue Estimates - MSN

May 15, 2025
pulisher
May 15, 2025

What You Need To Know About The ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) Analyst Downgrade Today - Yahoo Finance

May 15, 2025
pulisher
May 15, 2025

Analysts Have Just Cut Their ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) Revenue Estimates By 15% - simplywall.st

May 15, 2025

Ars Pharmaceuticals Inc (SPRY) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$21.87
price up icon 3.40%
$35.60
price down icon 2.49%
$104.59
price up icon 1.67%
$28.27
price up icon 16.05%
$112.49
price up icon 1.66%
biotechnology ONC
$279.16
price up icon 3.51%
大文字化:     |  ボリューム (24 時間):